Meng-fan PENG, Bao-song LIU, Ming-san MIAO. Effect of Kidney-reinforcing Traditional Chinese Medicine in Treating Polycystic Ovary Syndrome[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(6): 204-209.
DOI:
Meng-fan PENG, Bao-song LIU, Ming-san MIAO. Effect of Kidney-reinforcing Traditional Chinese Medicine in Treating Polycystic Ovary Syndrome[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(6): 204-209. DOI: 10.13422/j.cnki.syfjx.20190405.
Effect of Kidney-reinforcing Traditional Chinese Medicine in Treating Polycystic Ovary Syndrome
Polycystic ovary syndrome (PCOS) is a common gynecological reproductive endocrine and metabolic disorder disease. The clinical manifestations of PCOS are diversified
with and no ovulation
insulin resistance
hyperinsulinemia and polycystic ovaries as the main pathological and physiological changes
which can lead to non-ovulation infertility and ovulatory dysfunction infertility
cause complications
such as amenorrhea
diabetes
lipid metabolism and glucose metabolism disorder
and endanger the long-term health of the body. Traditional Chinese medicine (TCM) does not have the name of this disease
and classifies PCOS to the category of " amenorrhea"
"infertility" and "abdominal mass kidney" according to its clinical manifestations. Compared with western medicine
TCM has a unique view in treating the disease
and believes that the disorders of liver
kidney and spleen functions jointly affect the occurrence and development of the disease. According to the literature review
kidney-deficiency syndrome is the main syndrome type of this disease
the kidney-tonifying method has achieved a good effect in clinic. Besides
the drug use is flexible and diversified
and both primary and secondary symptoms are taken into consideration. However
in the clinical application process
the application of kidney-tonifying method in PCOS has been affected by the thinking mode of "kidney-tonifying medicine for male diseases" to some extent. In view of this
the therapeutic effect of kidney-tonifying drugs in the treatment of PCOS is preliminarily demonstrated from several aspects of the relationship between kidney deficiency and reproduction
pathogenesis of PCOS
clinical research and experimental research of PCOS
in the expectation of providing theoretical and practical supports for kidney-tonifying therapy for PCOS and other gynecological diseases.
关键词
Keywords
references
Andrade V H , Mata A M , Borges R S , et al . Current aspects of polycystic ovary syndrome:a literature review [J]. Rev Assoc Med Bras , 2016 , 62 ( 9 ) : 867 - 871 .
Kurowska P , Barbe A , Rozycka M , et al . Apelin in reproductive physiology and pathology of different species: a critical review [J]. Int J Endocrinol , 2018 , doi: 10.1155/2018/9170480 doi:10.1155/2018/9170480 .
Mehta R , Kaur M , Gandhi P , et al . Auditory and visual reaction time in polycystic ovarian syndrome [J]. J Clin Diagn Res , 2018 , 12 ( 6 ): 11 - 13 .
Sasidevi A , Vellanki P , Kunselman A R , et al . Familial aggregation of circulating c-reactive protein in polycystic ovary syndrome [J]. Hum Reprod , 2013 , 28 ( 3 ): 770 - 776 .
Rutkowska, A Z , Diamanti-Kandarakis E. Polycystic ovary syndrome and environmental toxins [J]. Fertil Steril , 2016 , 106 ( 4 ): 948 - 958 .
SHI X , XIE X , JIA Y , et al . Associations of insulin receptor and insulin receptor substrates genetic polymorphisms with polycystic ovary syndrome:a systematic review and meta-analysis [J]. J Obstet Gynaecol Res , 2016 , 42 ( 7 ) : 844 - 854 .
Stewart D R , Dombroski B A , Urbanek M , et al . Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity [J]. J Clin Endocrinol Metab , 2006 , 91 ( 10 ) : 4112 - 4117 .
WEI L N , XIN C L , WANG W J , et al . Microarray analysis of obese women with polycystic ovary syndrome for key gene screening, key pathway identification and drug prediction [J]. Gene , 2018 , 661 : 85 - 94 .
Mantelli F , Moretti C , Macchi I , et al . Effects of sex hormones on ocular surface epithelia: lessons learned from polycystic ovary syndrome [J]. J Cell Physiol , 2016 , 231 ( 5 ) : 971 - 975 .
Vandenberg L N , Colborn T , Hayes T B , et al . Hormones and endocrinedisrupting chemicals: low-dose effects and nonmonotonic dose responses [J]. Endocr Rev , 2012 , 33 ( 3 ) : 378 - 455 .
Xita N , Tsatsoulis A. Review:fetal programming of polycystic ovary syndrome by androgen excess:evidence from experimental, clinical, and genetic association studies [J]. J Clin Endocr Metab , 2006 , 91 ( 5 ) : 1660 - 1666 .
Spritzer P M , Motta A B , Sierzega M , et al . Adolescence and polycystic ovary syndrome: current concepts on diagnosis and treatment [J]. Int J Clin Pract , 2015 , 69 ( 11 ) : 1236 - 1246 .
Differentiation and Treatment of Lipid Turbidity Disease Based on Theory of "Spleen Ascending and Stomach Descending"
Cold and Heat in Acute Coronary Syndrome: A Review
Pathogenesis and Traditional Chinese Medicine Prevention and Treatment Strategy of Diabetic Vascular Calcification Based on Theory of Stasis-toxin-deficiency
Syndrome Differentiation and Treatment of Rheumatoid Arthritis with Anemia Based on Traditional Chinese Medicine Theory of "Deficiency Caused by Toxic Heat"
Volatile Oils from Chinese Medicine in Prevention and Treatment of Breast Cancer: A Review
Related Author
SHEN Tao
ZHOU Xin
ZHANG Xiaobo
SONG Wei
ZHU Wenyu
HUANG Yun
YANG Lele
WANG Xuejiao
Related Institution
Chengdu University of TCM
Hospital of Chengdu University of Traditional Chinese Medicine (TCM)
Beijing University of Chinese Medicine
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
National Clinical Research Center for Cardiovascular Diseases of Traditional Chinese Medicine, Xiyuan Hospital of China Academy of Chinese Medical Sciences